4-Nitrophenyl (tert-butoxycarbonyl)-D-glutaminate

Catalog No. :
ACAXEI142
CAS No. :
74086-23-0
Molecular Formula :
C16H21N3O7
Molecular Weight :
367.36

IUPAC Name:4-nitrophenyl (tert-butoxycarbonyl)-D-glutaminate

4-Nitrophenyl (tert-butoxycarbonyl)-D-glutaminate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g95%$52.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Nitrophenyl (tert-butoxycarbonyl)-D-glutaminate
IUPAC Name4-nitrophenyl (tert-butoxycarbonyl)-D-glutaminate
MDL No.MFCD00056110
Molecular FormulaC16H21N3O7
Molecular Weight367.36
SMILESO=C(N)CC[C@H](C(OC1=CC=C([N+]([O-])=O)C=C1)=O)NC(OC(C)(C)C)=O
InChI KeyHJMMCTZLXOVMFB-GFCCVEGCSA-N
SynonymBOC-D-GLN-ONP;BOC-D-GLUTAMINE 4-NITROPHENYL ESTER;BOC-D-GLUTAMINE-ONP;(4-nitrophenyl) (2R)-5-amino-2-[(2-methylpropan-2-yl)oxycarbonylamino]-5-oxopentanoate;BOC-D-GLUTAMINE P-NITROPHENYL ESTER;N-ALPHA-T-BUTYLOXYCARBONYL-D-GLUTAMINE P-NITROPHENYL ESTER;T-BUTYLOXYCARBONYL-D-GLUTAMINE P-NITROPHENYL ESTER;α-aminoglutaramic acid
CAS No.74086-23-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302
Precautionary Statement(s)
P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACAXEI142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKPUE163 route compound structure diagram
    ACKPUE16361348-28-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAXEI142 route product structure diagram
    ACAXEI14274086-23-0 In Stock
Inquiry

2. ACAXEI142 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6 In Stock
  4. Then
  5. ACAXEI142 route product structure diagram
    ACAXEI14274086-23-0 In Stock
Inquiry

Comments (0)